As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...

Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...

A rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...

Companies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...

Tata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...

A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...

Investors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...

The Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...

Shriyan, a young cricket prodigy, displayed exceptional talent from a very early age, captivating audiences with his skills. Tragically, hi...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

The AI-powered startup offers cognitive assessments measuring attention, memory, and executive function, providing users with benchmarked s...

Amazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...

Anthropic acquires startup Coefficient Bio for about $400 million: report

An exchange note by TCS said that the new platform consolidates data currently residing on multiple systems within the enterprise into a ce...

Lupin would leverage Acceliant's clinical trial platform for its clinical research and trials across Lupin Research programs.

Pharm firms often deploy investigator platforms individually resulting in clinical sites using multiple environments, introducing complexit...